B
Barry H. Cohen
Researcher at New York University
Publications - 27
Citations - 2555
Barry H. Cohen is an academic researcher from New York University. The author has contributed to research in topics: Anxiety & Restless legs syndrome. The author has an hindex of 18, co-authored 27 publications receiving 2145 citations.
Papers
More filters
Journal ArticleDOI
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross,Anthony P. Bossis,Jeffrey Guss,Gabrielle Agin-Liebes,Tara C. Malone,Barry H. Cohen,Sarah E. Mennenga,Alexander B. Belser,Krystallia Kalliontzi,James Babb,Zhe Su,Patricia Corby,Brian L. Schmidt +12 more
TL;DR: Psilocybin was associated with enduring anxiolytic and anti-depressant effects in patients with cancer-related psychological distress, sustained benefits in existential distress and quality of life, as well as improved attitudes towards death.
Book
Explaining Psychological Statistics
TL;DR: The author revealed that students had had limited success with the one-size-fits-all pedagogical methods used in the first edition, but found the second edition to be more beneficial in terms of teaching and learning.
Book
Introductory Statistics for the Behavioral Sciences
TL;DR: This book presents a meta-modelling approach to inferential Statistics called Factorial Design: Two-Way Analysis of Variance, which automates the very labor-intensive and therefore time-heavy and expensive process of manually calculating correlations between data points.
Book
Essentials of Statistics for the Social and Behavioral Sciences
Barry H. Cohen,R. Brooke Lea +1 more
TL;DR: This work focuses on Null Hypothesis Testing and its applications to Nonparametric Statistics, and investigates the role of correlation and Regression in the design of hypotheses.
Journal ArticleDOI
Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?
Pinky Agarwal,Sanjeev Kumar,Subramanian Hariharan,Noam Eshkar,Piero Verro,Barry H. Cohen,Souvik Sen +6 more
TL;DR: In a small sample of stroke patients with a hyperdense middle cerebral artery sign, patients with HMCAS appeared to respond better to IA than IV rtPA, and using 90-day mRS ≤1 as an indicator of significant persistent improvement was similar.